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SUMMARY
Chromoblastomycosis (CR) is a subcutaneous chronic mycosis characterized by a granulomatous inflammatory response.
However, little is known regarding the pattern of leukocyte subsets in CR and the pathways involved in their recruitment. The
objective of this study was to assess the cellular subsets, chemokine, chemokine receptors and enzymes in CR. The inflammatory
infiltrate was characterized by immunohistochemistry using antibodies against macrophages (CD68), Langerhans’cells (S100),
lymphocytes (CD3, CD4, CD8, CD45RO, CD20 and CD56) and neutrophils (CD15). The expression of MIP-1α (Macrophage
inflammatory protein-1α), chemokine receptors (CXCR3 and CCR1) and enzymes (superoxide dismutase-SOD and nitric oxide
synthase-iNOS) was also evaluated by the same method. We observed an increase in all populations evaluated when compared
with the controls. Numbers of CD15+ and CD56+ were significantly lower than CD3+, CD4+, CD20+ and CD68+ cells. Statistical
analysis revealed an association of fungi numbers with CD3, CD45RO and iNOS-positive cells. Furthermore, MIP-1α expression
was associated with CD45RO, CD68, iNOS and CXCR3. Our results suggest a possible role of MIP-1α and fungi persistence in
the cell infiltration in CR sites.
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INTRODUCTION
Chromoblastomycosis (CR) is a chronic skin infection caused by
various members of the Dematiaceae family, including Fonsecaea
pedrosoi, Phialophora verrucosa, Fonsecaea compactum,
Cladosporium carrioni, Rinocladiella aquaspersa4-5,24.
Histopathologic findings of CR include pseudo-epitheliomatous
epidermal hyperplasia, hyperkeratosis, irregular acanthosis, alternating
with areas of atrophy and collection of inflammatory cells forming
epidermic abscesses. At the dermal level, a granulomatous reaction
with different grades of fibrosis7,26 can be observed. Fungi may be
observed among these structures or, more frequently, in the interior of
the giant cells, under the form of round hazel cells containing a distinct
membrane7,26. Besides the presence of macrophages, T lymphocytes
(CD4+ and CD8+), B lymphocytes, Langerhans’ cells and epithelioid
cells in the granulomas, a vast amount of polymorphonuclear (PMN)
cells and eosinophils infiltrating in the lesion can be observed3,7,22,26.
In this setting, expression of selective recruitors of these cell types,
such as chemokines, have not been previously assessed in CR.
Chemokine and chemokine receptors are responsible for the leukocyte
recruitment and activation in different inflammatory diseases25,27
including fungal infections23. Chemokines are classified into four
subfamilies according to the configuration of cysteine residues near
the N-terminal, depending on whether the first two cysteines are
separated (CXC, CX3C) or not (CC, C) by an intervening amino acid17-
18. Of these, MIP-1α (Macrophage inflammatory protein-1α, also
designated CCL3) is a CC chemokine with potent chemotactic activity
for various subsets of mononuclear leukocytes and also neutrophils13,15,17-
18,25,27, playing an important role in cellular responses in fungal
diseases14,16. MIP-1α is a ligand of CCR1, which is found on Th1 cells,
monocytes, macrophages1,20-21 and neutrophils27. Conversely, CXCR3
is expressed preferentially on Th1 lymphocytes and at lower levels in
Th2 cells, and its ligand comprises Mig, IP-10 and I-TAC1,20-21.
Although the distribution of immune cells has been previously
reported in the CR granulomas3,22, the pathways associated with
inflammatory cell recruitment at these sites are poorly understood.
Therefore, in order to better characterize the lesions of CR and the
cell-mediated immune reactivity, the present paper studied the
populations of macrophages, lymphocytes, neutrophils and
Langerhans’cells and their correlation with the expression of MIP-1α,
CXCR3, CCR1, enzymes and the persistence of fungi in CR sites.
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MATERIALS AND METHODS
Human subjects: Biopsies were obtained from 10 patients with
clinical and histopathological diagnosis of CR before the beginning of
treatment for diagnostic purposes. All samples were obtained under
institutionally approved protocols of the School of Medicine Ethical
Committee, University of Brasilia. The subjects of this study were 10
adult Brazilian patients with ages ranging from 52 to 73 years and
with no history of drug use or positivity for HIV. All specimens were
collected from foot and inferior limbs, the common clinical presentation
was a verrucous plaque with slow growth and evolution varied from 10
to 30 years. The control group comprised two samples of clinically
healthy skin of the face taken for esthetic purposes.
Tissue preparation: The samples were fixed in neutral buffered
formalin, embedded by a routine technique in paraffin wax and
sectioned at 5 µm for hematoxylin and eosin, Grocott and
immunohistochemical staining.
Immunohistochemistry: From the tissues embedded in paraffin
wax, 5-µm thick sections were cut and collected on gelatin-coated
glass slides. Briefly, the samples were immersed in 3 mM citrate buffer
(pH 6.0) for 10 minutes at 120 °C for antigen retrieval. Subsequently,
sections were incubated in 3% normal serum and then with one of the
following: mouse anti-human CD3 monoclonal antibody (M7193;
Dako, Glostrup, Denmark); mouse anti-human CD4 monoclonal
antibody (M0716, Dako); mouse anti-human CD8 monoclonal antibody
(M7103; Dako); mouse anti-human CD45RO monoclonal antibody
(M0742; Dako), mouse anti-human CD20 monoclonal antibody
(M0755; Dako), mouse anti-human CD68 monoclonal antibody
(M0876; Dako), mouse anti-human CD56 monoclonal antibody
(M07174; Dako), mouse anti-human CD15 monoclonal antibody
(M7074; Dako), rabbit anti-human S100 polyclonal antibody (Z0311;
Dako), rabbit anti-human iNOS polyclonal antibody (C-20; sc652, Santa
Cruz Biotechnology, Santa Cruz, CA, USA), rabbit anti-human SOD
polyclonal antibody (FL-154; sc11407, Santa Cruz), goat anti-human
MIP-1α polyclonal antibody (C-16; sc1381, Santa Cruz), goat anti-
human CXCR3 polyclonal antibody (C-20; sc6226, Santa Cruz), goat
anti-human CCR1 polyclonal antibody (C-20; sc6125, Santa Cruz).
All antibodies were diluted in PBS-BSA at 1:100, except anti-S100,
which was used at 1:500. After, the sections were incubated with
appropriate biotinylated antibodies (Dako) for 20 min. Sections were
then incubated with avidin-biotin complex (Kit LSAB-HRP, Dako).
After washing, the slides were counterstained with Mayer’s
hematoxylin. Negative controls were obtained by the omission of
primary antibodies.
Cell counting and statistical analysis: The CR specimens were
scored for the intensity of immunoexpression of each cell marker as
follows: discrete, immunostaining similar or two times stronger than
observed for control samples; moderate, immunostaining tree or four
times more intense than control; intense, immunostaining five times
more stronger than control. The number of muriform cells, identified
by Grocott stain and of positively stained cells for each antibody were
determined using an integration graticule (Carl Zeiss-4740680000000-
Netzmikrometer 12.5x). All cells were counted per five consecutive
microscopic high power fields (x400) and, in this magnification, each
field (integration graticule) has area of 0.015625 mm2; thus a total
area of 0.078125 mm2 was analyzed in each specimen. Results were
expressed as the mean of positive cells ± standard deviation (SD) of n
observations, per mm2. Data were analyzed using the Kruskal-Wallis
test followed by Dunn’s test. To examine the relationship between the
fungi population, infiltrating cells, chemokine, chemokine receptors
and enzymes, simple regression analysis was performed. All statistical
tests were performed using the SPSS 10.0 software.
RESULTS
In the present study, by means of routine HE staining followed by
Grocott staining, the main microscopic characteristics of CR were
observed. A granulomatous inflammatory disease was characterized
by the presence of aggregates of T and B lymphocytes (Fig. 1A, B, C,
D, E and F), eosinophils, neutrophils (Fig. 1G) forming microabscess,
and macrophages (Fig. 1H). Only discrete areas of fibrosis were
detected in all samples. Muriform cells were identified scattered in
the connective tissue or inside microabscesses as well as within giant
cells, with routine HE and Grocott stain.
As observed in Figure 1I, S100 positive cells were mostly restricted
to the cells in the epithelium basal layer. The SOD expression (Fig.
1N) varied from moderate (11.1%) to intense (88% of cases). On the
other hand, iNOS expression (Fig. 1M) varied from discrete (11.1%)
to moderate (88% of cases). The iNOS expression was mostly linked
to macrophages and multinucleated giant cells, while SOD expression
was found in neutrophils, macrophages and epithelial cells. CCR1 (Fig.
1J) and CXCR3 expression (Fig. 1K) were most detected on
mononuclear cells. The expression of MIP-1α (Fig. 1L) varied from
moderate to intense and was linked to macrophages and multinucleated
giant cells and also to the extracellular matrix. Controls exhibited
negative expression for SOD (Fig. 1O) as well as for all analyzed
markers (data not shown). No positive staining was observed when
primary antibodies were omitted.
An increase in all cell populations analyzed was observed (Fig. 2A)
when compared to the controls (Fig. 2B). A significantly high proportion
of CD3+ (p = 0.0031), CD4+ (p = 0.0404), CD20+ (p = 0.012) and CD68+
(p = 0.0023) were observed in relation to CD15+. Furthermore, CD56+
numbers were lower when compared to CD3+ (p = 0.0035), CD4+ (p =
0.0452), CD20+ (p = 0.014) and CD68+ (p = 0.0057). The numbers of
CD68+ were significantly higher than CD8+ cells (p = 0.043). No
differences between other cell types were detected (Fig. 2).
Statistical regression analysis revealed a significant association of
the fungal load with CD3+ and activated lymphocytes (CD45RO+) and
with iNOS positive cells. Furthermore, MIP-1α expression was found
to be associated with CD45RO, CD68, iNOS and CXCR3
immunolabeled cells (Table 1). No correlations were observed between
cell markers and CCR1 (data not shown).
DISCUSSION
Our results showed increased numbers of all cell markers analyzed
when compared to the healthy skin controls obtained from the face.
High proportions of CD3+, CD4+, CD20+ and CD68+ cells in relation to
other cells subsets, especially CD15+ and CD56+, were also observed.
In contrast to previous studies3, which detected a higher number of
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CD45RO+ in relation to CD68+, we observed similar populations of
these two cell types. Moreover, these authors also found an increased
number of CD8+ compared with CD4+ cells, while no difference between
these cells were found in our study. This apparent discrepancy could
be consequence of differences in the age and severity of the pathological
process, and/or fungal infections, while there is significant variation
in the evolution of cases and clinical presentation of lesions when
comparing both studies. It must be taken in account that control samples
even obtained from different anatomical sites than CR samples, could
eventually explain the discrepancy found. Despite the differences found
in CR lesions, patients with CR did not exhibit variation in the peripheral
blood lymphocyte populations from control patients11. Additionally,
Fig. 2 - Number of lymphocytes (CD3, CD4, CD8, CD45RO, CD20 and CD56), neutrophils (CD15), macrophages (CD68), iNOS, CCR1, MIP-1α, CXCR3 and muriform cells per mm2 in a
representative lesion of chromoblastomycosis (A) and control healthy skin (B). Results represent mean ± SEM of positive cells in five fields. *Indicates difference in relation to respective
controls; +Indicates difference in relation to CD3, CD4 and CD20; #Indicates difference in relation to CD68.
Table 1
Simple regression analysis of inflammatory cells, fungi population and MIP-1α
expression in chromoblastomycosis lesions
x Fungi MIP-1α
y
Cell markers p R square p R square
CD3 0.09* 0.849 0.151 0.440
CD4 0.198 0.373 0.236 0.326
CD8 0.149 0.443 0.559 0.092
CD45RO 0.014* 0.812 0.055# 0.644
C15 0.404 0.179 0.111 0.509
CD20 0.220 0.588 0.485 0.128
CD56 0.287 0.274 0.262 0.298
CD68 0.554 0.094 0.046* 0.670
iNOS 0.007* 0.862 0.069# 0.398
MIP-α 0.633 0.063 - -
CCR1 0.279 0.281 0.574 0.086
CXCR3 0.818 0.015 0.071# 0.599
Simple regression analysis was performed comparing two variables (cell markers
vs. fungi numbers and vs. MIP-1α). R square indicates the percentage of variation
of variable y that is explained by variable x. * p values significant at level of 5%;
# p values significant at level of 10%.
Fig. 1 - Immunohistochemical staining of (A) CD3 (x400), (B) CD4 (x200), (C) CD8 (x200),
(D) CD45RO (x200), (E) CD20 (x200), (F) CD56 (x200), (G) CD15 (x200), (H) CD68
(x200), (I) S100 (x200), (J) CCR1 (x200), (K) CXCR3 (x400), (L) MIP-1a (x400), (M)
iNOS (x400) and (N) SOD (x400) positive cells in chromoblastomycosis lesions. (O) Negative
control (x200) of healthy skin showing negative staining for SOD.
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we observed an increase in eosinophil count, which may act as effector
cells in fungal infection9.
Our results suggest that MIP-1α may participate in the host defense
by attracting CD45RO+, CD68+ and iNOS-producing cells; although it
should be considered that these cells may be functioning as a source of
MIP-1α in CR. Indeed, most of the MIP-1α expression was localized
in mononuclear cells. Moreover, different cell sources, such as
neutrophils, fibroblasts and epithelial cells may potentially account
for chemokine production in CR. It has been shown that MIP-1α has a
critical role in the leukocyte infiltration in response to Aspergillus
fumigatus14 and cryptococcal Ags16.
With regard to chemokine receptors, we observed significant
numbers of CCR1 and CXCR3-positive cells in relation to controls.
Surprisingly, we did not observe any positive association between CCR1
and its ligand, MIP-1α. However, MIP-1α could function as a ligand
of another receptor, such as CCR5, or other chemokines may function
as ligands for CCR117-18; thus, this relationship needs to be further
explored in CR. In contrast, the expression of CXCR3 was found to be
associated with MIP-α, suggesting that this chemokine may be active
in the recruitment of CXCR3-positive cells, as previously
demonstrated25, or that even cells expressing CXCR3 act as a source
of MIP-α in CR sites13.
Our results also point to the involvement of fungus persistence in
the continuous influx of cells to the site of infection, particularly activated
and non-activated lymphocytes and iNOS positive cells. Similarly to
others, we observed various muriform cells of the fungus in the lesions,
both inside the cytoplasm of the macrophages and dispersed in the
connective tissue, possibly suggesting phagocytes incompetence
destroying the fungus26 that may be related to the degree of severity of
cases included in our study (duration over 10 years). The persistence of
Fonsecae pedrosoi in CR seems to be related to the inefficiency of the
microbicidal mechanisms of the activated macrophages19. Furthermore,
F. pedrosoi melanin inhibits fungi internalization8 and nitric oxide
production by in vitro macrophages (unpublished results). Despite their
association with fungal population, iNOS-positive cells showed a
predominantly moderate expression associated with macrophage and
multinucleated giant cells, even when fungi were observed inside these
cells. On the other hand, expression of SOD, which converts superoxide
radicals into less damaging hydrogen peroxide reactive oxygen
intermediates, was intense in most cases and, in accordance with this




production of Fonsecaea pedrosoi-infected macrophages (unpublished
results). In fact, the activity of SOD enzyme has been shown to be
increased following infection by intracellular pathogens12 and may
indicate significant intracellular oxidant activity.
Although no defective humoral response has been observed in
CR6,11, patients with CR have suppressed cellular immune responses
to fungal antigens10. Furthermore, the cell-mediated immune response
is a determinant of the CR clinical presentation, with the T cell
proliferative response to chromoAg and levels of IFN-γ progressively
diminished and the increased IL-10 levels according to the severity of
disease11. Taken together, these results can account for the moderate
iNOS expression observed in our study, given that IFN-γ and IL-10
have roles in stimulating and inhibiting iNOS production, respectively,
by macrophages2. Therefore, it seems that the balance between the T-
cell response and consequent macrophage activation may play a
regulatory role in determining the outcome and fungal destruction in
CR infections.
In conclusion:
• The fungal persistence seems to be associated with inefficient
immune response that does not effectively destroy the fungus.
• The continuous antigenic stimuli, caused by fungal persistence,
are probably a contributing factor to the progressive inflammatory
cell infiltration in CR lesions.
• The chemokine MIP-1α displays a role in the recruitment of effector
cells and may be a potential target for augmentation of the antifungal
activity and improvement of the outcome of the infection in CR.
RESUMO
Padrão de infiltração de células do sistema imune na
cromomicose: envolvimento de MIP-1 alfa da persistência
fúngica
A cromomicose é micose subcutânea crônica sistêmica
caracterizada por resposta inflamatória crônica granulomatosa. No
entanto, existem poucos dados a respeito do padrão de subtipos de
leucócitos na cromomicose e sobre as vias envolvidas no recrutamento
destas células. O objetivo deste trabalho foi avaliar os tipos celulares,
bem como a expressão de quimiocinas, receptores de quimiocinas e
enzimas em lesões de cromomicose. O infiltrado inflamatório foi
caracterizado por meio de técnica imuno-histoquímica utilizando os
seguintes marcadores CD68 (macrófagos), S100 (células de
Langerhans), CD3, CD4, CD8, CD45RO, CD20 e CD56 (linfócitos) e
CD15 (neutrófilos). A expressão de MIP-1α (Proteína Inflamatória do
Macrófago-1α), receptores de quimiocinas (CXCR3 e CCR1) e enzimas
(superóxido dismutase-SOD e óxido nítrico sintase induzida-iNOS)
foi avaliada pelo mesmo método. Observou-se um aumento de todas
as populações celulares avaliadas em relação às amostras controle. As
populações de células CD15+ e CD56+ foram significativamente
menores que células CD3+, CD4+, CD20+ e CD68+. A análise estatística
revelou uma correlação positiva entre o número de fungos com as
células CD3, CD45RO e iNOS-positivas. A expressão de MIP-1α foi
também associada às populações de células CD45RO, CD68, iNOS e
CXCR3 positivas. Nossos resultados apontam para um possível papel
de MIP-1α e da persistência fúngica na infiltração de células
inflamatórias nos sítios de cromomicose.
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